Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Background Breast cancer (BC) is the most common cancer in women globally. The North Africa and Middle East (NAME) region is coping hard with the burden of BC. We aimed to present the latest epidemiology of BC and its risk factors in this region. Methods We retrieved the data on BC burden and risk factors from the Global Burden of Disease Study 2019 to describe BC status in the 21 countries of the NAME region from 1990 to 2019. We explored BC incidence, prevalence, deaths, disability-adjusted life years (DALYs), and attributable burden to seven risk factors of female BC, namely, alcohol use, diet high in red meat, low physical activity, smoking, secondhand smoke, high body mass index, and high fasting plasma glucose. Decomposition analysis on BC incidence trend was done to find out the contributing factors to this cancer’s growth. Results In 2019, there were 835,576 (95% uncertainty interval: 741,968 to 944,851) female and 10,938 (9,030 to 13,256) male prevalent cases of BC in the NAME region. This number leads to 35,405 (30,676 to 40,571) deaths among female patients and 809 (654 to 1,002) deaths in male patients this year. BC was responsible for 1,222,835 (1,053,073 to 1,411,009) DALYs among female patients in 2019, with a greater proportion (94.9%) of burden in years of life lost (YLLs). The major contributor to female BC incidence increase in the past three decades was found to be increase in age-specific incidence rates of BC (227.5%), compared to population growth (73.8%) and aging (81.8%). The behavioral risk factors were responsible for majority of attributable female BC burden (DALYs: 106,026 [66,614 to 144,247]). High fasting plasma glucose was found to be the risk factor with the largest effect (DALYs: 84,912 [17,377 to 192,838]) on female BC burden. Conclusion The increasing incidence and burden of BC in the NAME region is remarkable, especially when considering limited resources in the developing countries of this region. Proper policies like expanding screening programs and careful resource management are needed to effectively manage BC burden.

[1]  M. Naghavi,et al.  National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019 , 2023, Breast Cancer Research.

[2]  H. Baradaran,et al.  Patterns of better breast cancer care in countries with higher human development index and healthcare expenditure: Insights from GLOBOCAN 2020 , 2023, Frontiers in Public Health.

[3]  Lin F. Yang,et al.  The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet.

[4]  F. Farzadfar,et al.  Expansion of the quality of care index on breast cancer and its risk factors using the global burden of disease study 2019 , 2022, Cancer medicine.

[5]  Ali Kazemi Karyani,et al.  Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet.

[6]  Vijay Kumar Chattu,et al.  Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 , 2021, JAMA oncology.

[7]  Vijay Kumar Chattu,et al.  The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. , 2021, The Lancet. Oncology.

[8]  Julia Omar,et al.  Breast Cancer Risk From Modifiable and Non-Modifiable Risk Factors among Palestinian Women: A Systematic Review and Meta-Analysis , 2021, Asian Pacific journal of cancer prevention : APJCP.

[9]  M. Tirona,et al.  An updated review of epidemiology, risk factors, and management of male breast cancer , 2021, Medical Oncology.

[10]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[11]  F. Farzadfar,et al.  Epidemiologic pattern of cancers in Iran; current knowledge and future perspective , 2020, Journal of Diabetes & Metabolic Disorders.

[12]  R. Bendardaf,et al.  Incidence and Clinicopathological Features of Breast Cancer in the Northern Emirates: Experience from Sharjah Breast Care Center , 2020, International journal of women's health.

[13]  Dan J Stein,et al.  Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[14]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[15]  Suhad Daher-Nashif,et al.  Psychosocial Aspects of Female Breast Cancer in the Middle East and North Africa , 2020, International journal of environmental research and public health.

[16]  Ravensara S. Travillian,et al.  Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, The Lancet.

[17]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[18]  Xin Hu,et al.  The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017 , 2020, Frontiers in Oncology.

[19]  E. Fernández,et al.  Burden of disease from breast cancer attributable to smoking and second‐hand smoke exposure in Europe , 2020, International journal of cancer.

[20]  V. McCormack,et al.  Breast cancer early detection: A phased approach to implementation , 2020, Cancer.

[21]  A. Ng'ang'a,et al.  The role of dissemination and implementation science in global breast cancer control programs: Frameworks, methods, and examples , 2020, Cancer.

[22]  C. Adebamowo,et al.  Breast cancer treatment: A phased approach to implementation , 2020, Cancer.

[23]  Amy M. Sitapati,et al.  Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[24]  Xinbao Hao,et al.  Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017 , 2020, Breast Cancer Research and Treatment.

[25]  J. Canner,et al.  Male breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database , 2020, Breast Cancer Research and Treatment.

[26]  H. Salehiniya,et al.  Survival Rate of Breast Cancer in Eastern Mediterranean Region Countries: A Systematic Review and Meta-Analysis , 2019, Annals of global health.

[27]  R. Sankaranarayanan,et al.  Strengthening the early detection of common cancers in the Eastern Mediterranean Region. , 2019, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[28]  K. Kyriacou,et al.  The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries , 2019, Human mutation.

[29]  Su-zhan Zhang,et al.  Global patterns and trends in the breast cancer incidence and mortality according to sociodemographic indices: an observational study based on the global burden of diseases , 2019, BMJ Open.

[30]  Eun Sug Park,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 , 2019, JAMA Oncology.

[31]  Farid Zayeri,et al.  Global Trend of Breast Cancer Mortality Rate: A 25-Year Study , 2019, Asian Pacific journal of cancer prevention : APJCP.

[32]  Shigui Yang,et al.  Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases , 2019, BMJ Open.

[33]  A. Mokdad,et al.  Burden of Breast Cancer in the Arab World: Findings from Global Burden of Disease, 2016 , 2018, Journal of epidemiology and global health.

[34]  László Tabár,et al.  The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening , 2018, Cancer.

[35]  A. Kabir,et al.  Tehrān , 2018, Voices from Zoroastrian Iran.

[36]  J. Ferlay,et al.  Global cancer incidence in older adults, 2012 and 2035: A population‐based study , 2018, International journal of cancer.

[37]  Sara R. Selitsky,et al.  Male breast cancer: a disease distinct from female breast cancer , 2018, Breast Cancer Research and Treatment.

[38]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[39]  F. Bray,et al.  Proportion of cancers attributable to major lifestyle and environmental risk factors in the Eastern Mediterranean region , 2018, International journal of cancer.

[40]  Ronan A Lyons,et al.  Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 , 2018, The Lancet.

[41]  R. Sullivan,et al.  Cancer Care for Refugees and Displaced Populations: Middle East Conflicts and Global Natural Disasters. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[42]  Gbd Eastern Mediterranean Region Neonatal,et al.  Neonatal, infant, and under-5 mortality and morbidity burden in the Eastern Mediterranean region: findings from the Global Burden of Disease 2015 study , 2018 .

[43]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[44]  R. Atun,et al.  Health system barriers and enablers to early access to breast cancer screening, detection, and diagnosis: a global analysis applied to the MENA region. , 2017, Public health.

[45]  M. Akram,et al.  Awareness and current knowledge of breast cancer , 2017, Biological Research.

[46]  Z. Andersen,et al.  Active smoking and risk of breast cancer in a Danish nurse cohort study , 2017, BMC Cancer.

[47]  T. H. Nguyen,et al.  Burden of cancer in the Eastern Mediterranean Region, 2005–2015: findings from the Global Burden of Disease 2015 Study , 2017, International Journal of Public Health.

[48]  Alan D. Lopez,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study , 2017, JAMA oncology.

[49]  F. Bray,et al.  Profile of cancer in the Eastern Mediterranean region: The need for action. , 2017, Cancer epidemiology.

[50]  S. Payne,et al.  Barriers to, and opportunities for, palliative care development in the Eastern Mediterranean Region. , 2017, The Lancet. Oncology.

[51]  W. Maziak,et al.  Cancer Care at Times of Crisis and War: The Syrian Example , 2016, Journal of global oncology.

[52]  H. Salehiniya,et al.  Incidence and Mortality and Epidemiology of Breast Cancer in the World. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[53]  T. Vos,et al.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.

[54]  W. Gradishar,et al.  NCCN Guidelines Updates: Breast Cancer. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[55]  M. Elwood,et al.  Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology , 2016, BMC Cancer.

[56]  L. Fan,et al.  Current Status and Future Projections of Breast Cancer in Asia , 2015, Breast Care.

[57]  J. Lortet-Tieulent,et al.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.

[58]  E. McGowan,et al.  Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer? , 2015, BioMed research international.

[59]  Y. Bignon,et al.  BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African , 2015, Disease markers.

[60]  P. Boffetta,et al.  Features of breast cancer in developing countries, examples from North-Africa. , 2014, European journal of cancer.

[61]  M. Coccia The effect of country wealth on incidence of breast cancer , 2013, Breast Cancer Research and Treatment.

[62]  M. Thun,et al.  Active smoking and breast cancer risk: original cohort data and meta-analysis. , 2013, Journal of the National Cancer Institute.

[63]  P. Reynolds Smoking and Breast Cancer , 2013, Journal of Mammary Gland Biology and Neoplasia.

[64]  M Smans,et al.  Diabetes and breast cancer risk: a meta-analysis , 2012, British Journal of Cancer.

[65]  M. Elkind Epidemiology and Risk Factors , 2011, Continuum.

[66]  A. Buzaid,et al.  Identifying important breast cancer control strategies in Asia, Latin America and the Middle East/North Africa , 2011, BMC health services research.

[67]  H. Sørensen,et al.  Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case–Control Study in Denmark , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[68]  Mohammad Jahanzeb,et al.  The process of NCCN guidelines adaptation to the Middle East and North Africa region. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[69]  F. Geara,et al.  Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[70]  R. Carlson,et al.  Guideline implementation for breast healthcare in low‐income and middle‐income countries , 2008, Cancer.

[71]  Bernard Rachet,et al.  Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.

[72]  F. Schmidt Meta-Analysis , 2008 .

[73]  C. la Vecchia,et al.  The burden of cancer attributable to alcohol drinking , 2006, International journal of cancer.

[74]  Siegal Sadetzki,et al.  Diabetes mellitus and breast cancer. , 2005, The Lancet. Oncology.

[75]  A. Ellis Breast , 2002, BMJ : British Medical Journal.

[76]  C. Yip,et al.  Spectrum of Breast Cancer in Malaysian Women: Overview , 2003, World Journal of Surgery.

[77]  서정헌,et al.  반도체 공정 overview , 2001 .

[78]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[79]  L. Mula-Hussain,et al.  Cancer in War-Torn Countries: Iraq as an Example , 2021, Handbook of Healthcare in the Arab World.

[80]  W. Gradishar,et al.  NCCN Guidelines Updates: Breast Cancer. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[81]  Ali Jad Abdelwahab Yousef Male Breast Cancer: Epidemiology and Risk Factors. , 2017, Seminars in oncology.

[82]  A META-ANALYSIS OF THE LITERATURE , 2017 .

[83]  C. Panis,et al.  Breast cancer in Brazil: epidemiology and treatment challenges. , 2015, Breast cancer.

[84]  Kathryn J Ruddy,et al.  The Epidemiology of Male Breast Cancer , 2015, Current Oncology Reports.

[85]  C. Panis,et al.  Breast cancer in Brazil: epidemiology and treatment challenges , 2015 .

[86]  I. Romieu,et al.  Nutrition and breast cancer. , 2014, Maturitas.

[87]  N. Khanjani,et al.  Causes of delay in seeking treatment in patients with breast cancer in Iran: a qualitative content analysis study. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[88]  Changhua Wang,et al.  Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[89]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[90]  F. Savage,et al.  The need for action , 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.